Study of Non Inferiority Bi-Profenid® 200mg Versus Bi-Profenid® 300mg Among Patients Presenting of the Post-traumatic or Rheumatologic Acute Affections of the Locomotor Apparatus (BIPROPAIN)
Clinical trial NCT00810121 · COMPLETED
Trial details
- NCT number
- NCT00810121
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2009-06-01
- Enrollment
- 409
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.